Annual Report 2019

Surgical Center

R.Hayashi, C. Saito

Introduction

 The Surgical Center performs function-preserving operations for ordinary cancer patients as much as possible, taking into consideration patient quality of life (QOL), but depending on the case, extended surgeries are performed to cure localized highly progressive cancers. Also, thoracoscopic and laparoscopic surgeries are routinely indicated for the treatment of various cancer patients.

The Team and What We Do

 In this period (2019.4-2020.3), 3883 cases underwent surgical treatment (Table 1). To preserve organ functions, limited resection or reconstructive operations are indicated in our hospital. These procedures include vertical partial laryngectomy for voice preservation, breast-conserving surgery, total mastectomy with breast reconstruction, pancreas-sparing duodenectomy, partial anal sphincter preserving surgery, and bladder-sparing surgery.

 With refinements in laparoscopic instruments and advances in surgical experience, laparoscopic surgery is a safe alternative for selected patients with malignant neoplasms, and has fulfilled its indications. In our hospital, laparoscopic surgery has been introduced in the esophageal, thoracic, gastric, colorectal, hepatobiliary, pancreatic, urology and gynecology divisions. A robotic surgical system has been in use to provide less-invasive surgery since 2014. The system was indicated for prostate, renal, and gastric cancer. The robotic surgery was introduced for esophageal and lung cancer in 2020.

Table 1. Total number of operations

Education

 We place importance on the education of young surgeons. All surgical groups have their own training programs for resident surgeons. Many surgeons from domestic and foreign hospitals have visited our center to learn surgical techniques.